Arax Advisory Partners’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
RCMNY
ACM
PAI
Arax Advisory Partners's PRTA Position: Q2 2026 in Review
Arax Advisory Partners increased its Prothena Corp (PRTA) stake by 5,783% in Q2 2026, buying an estimated $52.5K and bringing the position to 5,412 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.
Arax Advisory Partners first reported a position in PRTA in Q3 2025 and has held it in 4 quarters since. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.
- Arax Advisory Partners held 5,412 shares of Prothena Corp worth $53K as of Q2 2026.
- Arax Advisory Partners bought 5,320 Prothena Corp shares in Q2 2026, an estimated $52.5K.
- Prothena Corp made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3218 holding.
- Arax Advisory Partners first reported a position in Prothena Corp in Q3 2025 and has held it in 4 quarters since.
- 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.